Advertisement

Engineering approaches for cardiac organoid formation and their characterization

Published:August 19, 2022DOI:https://doi.org/10.1016/j.trsl.2022.08.009
      Cardiac organoids are 3-dimensional (3D) structures composed of tissue or niche-specific cells, obtained from diverse sources, encapsulated in either a naturally derived or synthetic, extracellular matrix scaffold, and include exogenous biochemical signals such as essential growth factors. The overarching goal of developing cardiac organoid models is to establish a functional integration of cardiomyocytes with physiologically relevant cells, tissues, and structures like capillary-like networks composed of endothelial cells. These organoids used to model human heart anatomy, physiology, and disease pathologies in vitro have the potential to solve many issues related to cardiovascular drug discovery and fundamental research. The advent of patient-specific human-induced pluripotent stem cell-derived cardiovascular cells provide a unique, single-source approach to study the complex process of cardiovascular disease progression through organoid formation and incorporation into relevant, controlled microenvironments such as microfluidic devices. Strategies that aim to accomplish such a feat include microfluidic technology-based approaches, microphysiological systems, microwells, microarray-based platforms, 3D bioprinted models, and electrospun fiber mat-based scaffolds. This article discusses the engineering or technology-driven practices for making cardiac organoid models in comparison with self-assembled or scaffold-free methods to generate organoids. We further discuss emerging strategies for characterization of the bio-assembled cardiac organoids including electrophysiology and machine-learning and conclude with prospective points of interest for engineering cardiac tissues in vitro.

      Keywords

      Abbreviations:

      ALP (alkaline phosphatase), α-SMA (alpha-smooth muscle actin), BECs (blood vascular endothelial cells), bFGF (basic fibroblast growth factor), CFs (cardiac fibroblasts), CMs (cardiomyocytes), CVD (cardiovascular diseases), Cx43 (connexin 43), DE (differential expression), ECs (endothelial cells), ECM (extracellular matrix), EMT (epithelial to mesenchymal), EPHYS (electrophysiology), FTIR (fourier transformed infrared), GelMA (gelatin methacryloyl), GLMs (generalized linear models), GO (gene ontology), GSEA (gene set enrichment analysis), hCS (human cerebral cortex), hiPSC (human induced pluripotent stem cell), hMSCs (human mesenchymal stem cells), hSpS (human hindbrain/cerebral cortex), HUVECs (human umbilical vein endothelial cells), HyA (hyaluronic acid), LECs (lymphatic endothelial cells), LV (left ventricle), MEA (microelectrode arrays), MPSs (microphysiological systems), NIPAAM (N-isopropyl acrylamide), PCL (Poly(ε-caprolactone)), PDMS (polydimethylsiloxane), PEDOT (Poly(3,4- ethylenedioxythiophene)), PEG (polyethylene glycol), PGA (polyglycolide), PGS (polyglycerol sebacate), PLA (Poly(L-lactide)), PLGA (Poly(lactide-co-glycolide)), PSS (polystyrene sulfonate), PPy (polypyrrole), RNA (ribonucleic acid), RNA-seq (RNA sequencing), SEM (scanning electron microscopy), scRNA-seq (single-cell RNA sequencing), SLA (stereolithography), TEM (transmission electron microscopy), TGF β (transforming growth factor), VEGF (vascular endothelial growth factor)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Janssen P.M.
        • et al.
        Preservation of contractile characteristics of human myocardium in multi-day cell culture.
        J mol cellular cardiol. 1999; 31: 1419-1427
        • Ronaldson-Bouchard K.
        • Vunjak-Novakovic G.
        Organs-on-a-chip: a fast track for engineered human tissues in drug development.
        Cell stem cell. 2018; 22: 310-324
        • Gimbrone Jr M.A.
        • García-Cardeña G.
        Endothelial cell dysfunction and the pathobiology of atherosclerosis.
        Circulation res. 2016; 118: 620-636
        • Lalit P.A.
        • et al.
        Induced pluripotent stem cells for post–myocardial infarction repair: remarkable opportunities and challenges.
        Circulation res. 2014; 114: 1328-1345
        • Mak I.W.Y.
        • Evaniew N.
        • Ghert M.
        Lost in translation: animal models and clinical trials in cancer treatment.
        Am j transl res. 2014; 6: 114
        • Sanz-Nogues C.
        • O'Brien T.
        In vitro models for assessing therapeutic angiogenesis.
        Drug Discovery Today. 2016; 21: 1495-1503
        • Nsair A.
        • MacLellan W.R.
        Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.
        Advanced drug delivery rev. 2011; 63: 324-330
        • Morin K.T.
        • Tranquillo R.T.
        In vitro models of angiogenesis and vasculogenesis in fibrin gel.
        Experimental cell res. 2013; 319: 2409-2417
        • Prestwich G.D.
        • Healy K.E.
        Why regenerative medicine needs an extracellular matrix.
        Taylor & Francis, United Kingdom2015: 3-7
        • Briquez P.S.
        • et al.
        Design principles for therapeutic angiogenic materials.
        Nature Rev Materials. 2016; 1: 1-15
        • Wang C.
        • et al.
        Maladaptive contractility of 3D human cardiac microtissues to mechanical nonuniformity.
        Advanced healthcare materials. 2020; 91901373
        • Veldhuizen J.
        • et al.
        Engineering anisotropic human stem cell-derived three-dimensional cardiac tissue on-a-chip.
        Biomaterials. 2020; 256120195
        • Ma C.
        • et al.
        Organ-on-a-Chip: A New Paradigm for Drug Development.
        Trends Pharmacol Sci. 2021; 42: 119-133
        • Andrysiak K.
        • Stępniewski J.
        • Dulak J.
        Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.
        Pflugers Arch. 2021; 473: 1061-1085
        • Belair D.G.
        • et al.
        Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells.
        Stem cell rev rep. 2015; 11: 511-525
        • Yoder M.C.
        Differentiation of pluripotent stem cells into endothelial cells.
        Current opinion in hematol. 2015; 22: 252
        • Wilson H.K.
        • et al.
        Concise review: Tissue-specific microvascular endothelial cells derived from human pluripotent stem cells.
        Stem cells. 2014; 32: 3037-3045
        • Lian X.
        • et al.
        Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling.
        Proc Natl Acad Sci. 2012; 109: E1848-E1857
        • Kusuma S.
        • et al.
        Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix.
        Proc Natl Acad Sci U S A. 2013; 110: 12601-12606
        • Bao X.
        • et al.
        Chemically-defined albumin-free differentiation of human pluripotent stem cells to endothelial progenitor cells.
        Stem cell res. 2015; 15: 122-129
        • Lian X.
        • et al.
        Efficient differentiation of human pluripotent stem cells to endothelial progenitors via small-molecule activation of WNT signaling.
        Stem cell rep. 2014; 3: 804-816
        • Harding A.
        • et al.
        Highly efficient differentiation of endothelial cells from pluripotent stem cells requires the MAPK and the PI3K pathways.
        Stem Cells. 2017; 35: 909-919
        • Prasain N.
        • et al.
        Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony–forming cells.
        Nature biotechnol. 2014; 32: 1151-1157
        • Adams W.J.
        • et al.
        Functional vascular endothelium derived from human induced pluripotent stem cells.
        Stem cell reports. 2013; 1: 105-113
        • Youssef A.A.
        • et al.
        The promise and challenge of induced pluripotent stem cells for cardiovascular applications. JACC.
        Basic to translational sci. 2016; 1: 510-523
        • Lee S.
        • et al.
        Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubes.
        Biomaterials. 2015; 63: 158-167
        • Marcelo K.L.
        • Goldie L.C.
        • Hirschi K.K.
        Regulation of endothelial cell differentiation and specification.
        Circulation res. 2013; 112: 1272-1287
        • Sommer C.A.
        • Mostoslavsky G.
        Experimental approaches for the generation of induced pluripotent stem cells.
        Stem Cell Res Therapy. 2010; 1: 1-7
        • Zanotelli M.R.
        • et al.
        Stable engineered vascular networks from human induced pluripotent stem cell-derived endothelial cells cultured in synthetic hydrogels.
        Acta biomaterialia. 2016; 35: 32-41
        • Briquez P.
        • et al.
        Design principles for therapeutic angiogenic materials.
        Nature Rev Materials. 2016; 1: 15006
        • Rice J.J.
        • et al.
        Engineering the regenerative microenvironment with biomaterials.
        Adv Healthc Mater. 2013; 2: 57-71
        • Jha A.K.
        • et al.
        Enhanced survival and engraftment of transplanted stem cells using growth factor sequestering hydrogels.
        Biomaterials. 2015; 47: 1-12
        • Lu Y.
        • et al.
        Bioresponsive materials.
        Nature Reviews Materials. 2016; 2: 16075
        • Caliari S.R.
        • Burdick J.A.
        A practical guide to hydrogels for cell culture.
        Nat Methods. 2016; 13: 405-414
        • Natividad-Diaz S.L.
        • et al.
        A combined hiPSC-derived endothelial cell and in vitro microfluidic platform for assessing biomaterial-based angiogenesis.
        Biomaterials. 2019; 194: 73-83
        • Moya M.L.
        • et al.
        In vitro perfused human capillary networks.
        Tissue Eng Part C Methods. 2013; 19: 730-737
        • Belair D.G.
        • et al.
        Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells.
        Stem Cell Rev Rep. 2015; 11: 511-525
        • Rogozinski N.
        • et al.
        Current methods for fabricating 3D cardiac engineered constructs.
        iScience. 2022; 25104330
        • Hoang P.
        • et al.
        Generation of spatial-patterned early-developing cardiac organoids using human pluripotent stem cells.
        Nat Protoc. 2018; 13: 723-737
        • Malda J.
        • et al.
        25th anniversary article: Engineering hydrogels for biofabrication.
        Adv Mater. 2013; 25: 5011-5028
        • Plotkin M.
        • et al.
        The effect of matrix stiffness of injectable hydrogels on the preservation of cardiac function after a heart attack.
        Biomaterials. 2014; 35: 1429-1438
        • Caliari S.
        • et al.
        Stiffening hydrogels for investigating the dynamics of hepatic stellate cell mechanotransduction during myofibroblast activation.
        Scientific Reports. 2016; 6: 21387
        • Drakhlis L.
        • et al.
        Human heart-forming organoids recapitulate early heart and foregut development.
        Nature Biotechnol. 2021; 39: 737-746
        • Wang Q.
        • et al.
        Functional engineered human cardiac patches prepared from nature's platform improve heart function after acute myocardial infarction.
        Biomaterials. 2016; 105: 52-65
        • Guyette J.P.
        • et al.
        Bioengineering human myocardium on native extracellular matrix.
        Circ Res. 2016; 118: 56-72
        • Lewis-Israeli Y.R.
        • et al.
        Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease.
        Nat Commun. 2021; 12: 5142
        • Hofbauer P.
        • et al.
        Cardioids reveal self-organizing principles of human cardiogenesis.
        Cell. 2021; 184 (e22): 3299-3317
        • Voges H.K.
        • et al.
        Development of a human cardiac organoid injury model reveals innate regenerative potential.
        Development. 2017; 144: 1118-1127
        • Arai K.
        • et al.
        Fabrication of scaffold-free tubular cardiac constructs using a Bio-3D printer.
        PloS one. 2018; 13 (e0209162)e0209162-
        • Xiao Y.
        • et al.
        Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle.
        Lab Chip. 2014; 14: 869-882
        • Bahrami S.
        • et al.
        Microfluidic devices in tissue engineering, in Biomedical applications of microfluidic devices. Elsevier; Academic Press, Cambridge, MA, USA2021: 209-233
        • Sato M.
        • et al.
        Microcirculation-on-a-chip: A microfluidic platform for assaying blood-and lymphatic-vessel permeability.
        PloS one. 2015; 10e0137301
        • Truskey G.A.
        Human microphysiological systems and organoids as in vitro models for toxicological studies. 6. Frontiers in public health, Switzerland2018: 185
        • Zilberman-Rudenko J.
        • et al.
        Utility of microfluidic devices to study the platelet–endothelium interface.
        Platelets. 2017; 28: 449-456
        • Raasch M.
        • et al.
        Microfluidically supported biochip design for culture of endothelial cell layers with improved perfusion conditions.
        Biofabrication. 2015; 7015013
        • Lee S.
        • et al.
        Microfluidic-based vascularized microphysiological systems.
        Lab on a Chip. 2018; 18: 2686-2709
        • Cooper M.
        • Charest J.L.
        • Coppeta J.
        Design principles for dynamic microphysiological systems.
        Microfluidic Cell Culture Systems. Elsevier, 2019: 1-29
        • Kobuszewska A.
        • et al.
        Heart-on-a-Chip: an investigation of the influence of static and perfusion conditions on cardiac (H9C2) cell proliferation, morphology, and alignment.
        SLAS TECHNOLOGY: Translating Life Sciences Innovation. 2017; 22: 536-546
        • Sticker D.
        • et al.
        Multi-layered, membrane-integrated microfluidics based on replica molding of a thiol–ene epoxy thermoset for organ-on-a-chip applications.
        Lab on a Chip. 2015; 15: 4542-4554
        • Olanrewaju A.
        • et al.
        Capillary microfluidics in microchannels: from microfluidic networks to capillaric circuits.
        Lab on a Chip. 2018; 18: 2323-2347
        • Huebsch N.
        • et al.
        Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales.
        Tissue Eng Part C Methods. 2015; 21: 467-479
        • Sharma A.
        • et al.
        Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery.
        Cell Stem Cell. 2020; 26: 309-329
        • Chung A.S.
        • Ferrara N.
        Developmental and pathological angiogenesis.
        Annu Rev Cell Dev Biol. 2011; 27: 563-584
        • Coulombe K.L.
        • et al.
        Heart regeneration with engineered myocardial tissue.
        Annu Rev Biomed Eng. 2014; 16: 1-28
        • Wilson H.K.
        • et al.
        Concise review: tissue-specific microvascular endothelial cells derived from human pluripotent stem cells.
        Stem cells (Dayton, Ohio). 2014; 32: 3037-3045
        • Yoder M.C.
        Differentiation of pluripotent stem cells into endothelial cells.
        Curr Opin Hematol. 2015; 22: 252-257
        • Browne S.
        • Hossainy S.
        • Healy K.
        Hyaluronic Acid Macromer Molecular Weight Dictates the Biophysical Properties and in Vitro Cellular Response to Semisynthetic Hydrogels.
        ACS Biomaterials Sci Eng. 2020; 6: 1135-1143
        • Charrez B.
        • et al.
        Heart muscle microphysiological system for cardiac liability prediction of repurposed COVID-19 therapeutics.
        Front Pharmacol. 2021; 12684252
        • Lam S.F.
        • et al.
        Microfluidic device to attain high spatial and temporal control of oxygen.
        PloS one. 2018; 13 (e0209574-)e0209574
        • Weng K.C.
        • et al.
        Human induced pluripotent stem-cardiac-endothelial-tumor-on-a-chip to assess anticancer efficacy and cardiotoxicity.
        Tissue Eng Part C Methods. 2020; 26: 44-55
        • Glaser D.E.
        • et al.
        Organ-on-a-chip model of vascularized human bone marrow niches.
        Biomaterials. 2022; 280121245
        • Sun S.
        • et al.
        Progressive Myofibril Reorganization of Human Cardiomyocytes on a Dynamic Nanotopographic Substrate.
        ACS Applied Materials & Interfaces. 2020; 12: 21450-21462
        • Hoang P.
        • et al.
        Engineering spatial-organized cardiac organoids for developmental toxicity testing.
        Stem Cell Reports. 2021; 16: 1228-1244
        • Sances S.
        • et al.
        Human iPSC-derived endothelial cells and microengineered organ-chip enhance neuronal development.
        Stem Cell Reports. 2018; 10: 1222-1236
        • Browne S.
        • et al.
        Stem cell-based vascularization of microphysiological systems.
        Stem Cell Rep. 2021; 16: 2058-2075
        • Huebsch N.
        • et al.
        Metabolically driven maturation of human-induced-pluripotent-stem-cell-derived cardiac microtissues on microfluidic chips.
        Nature Biomed Eng. 2022; 6: 372-388
        • Lee-Montiel F.T.
        • et al.
        Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction.
        Front Pharmacol. 2021; 12667010
        • Pointon A.
        • et al.
        Cardiovascular microphysiological systems (CVMPS) for safety studies–a pharma perspective.
        Lab on a Chip. 2021; 21: 458-472
        • Albritton J.L.
        • et al.
        Ultrahigh-throughput generation and characterization of cellular aggregates in laser-ablated microwells of poly(dimethylsiloxane).
        RSC Advances. 2016; 6: 8980-8991
        • Au Sharma P.
        • Au C.
        Gentile, Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology.
        JoVE. 2021; : e61962
        • Zuppinger C.
        3D cardiac cell culture: a critical review of current technologies and applications.
        Frontiers in cardiovasc med. 2019; 6: 87
        • Pinto B.
        • et al.
        Three-dimensional spheroids as in vitro preclinical models for cancer research.
        Pharmaceutics. 2020; 12: 1186
        • Lazzari G.
        • Couvreur P.
        • Mura S.
        Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines.
        Polymer Chemistry. 2017; 8: 4947-4969
        • Joddar B.
        • et al.
        Development of functionalized multi-walled carbon-nanotube-based alginate hydrogels for enabling biomimetic technologies.
        Scientific Rep. 2016; 6: 32456
        • AnilKumar S.
        • et al.
        The applicability of furfuryl-gelatin as a novel bioink for tissue engineering applications.
        J Biomed Materials Res Part B: Applied Biomaterials. 2018; 107: 314-323
        • Anil Kumar S.
        • et al.
        A visible light-cross-linkable, fibrin–gelatin-based bioprinted construct with human cardiomyocytes and fibroblasts.
        ACS Biomaterials Sci Eng. 2019; 5: 4551-4563
        • Alonzo M.
        • et al.
        Hydrogel scaffolds with elasticity-mimicking embryonic substrates promote cardiac cellular network formation.
        Progress in biomaterials. 2020; 9: 125-137
        • Joddar B.
        • et al.
        A 3D bioprinted human cardiac cell platform to model the pathophysiology of diabetes. in circulation research.
        Am Heart Assoc. 2020; 127 (In this issue): A465
        • Roman B.
        • et al.
        A model for studying the biomechanical effects of varying ratios of collagen types I and III on cardiomyocytes.
        Cardiovas Eng Tech. 2021; 12: 311-324
        • Alonzo M.
        • El Khoury R.
        • Nagiah N.
        • Thakur V.
        • Chattopadhyay M.
        • Joddar B.
        3D Biofabrication of a cardiac tissue construct for sustained longevity and function.
        ACS Applied Materials & Interfaces. 2022; 14: 21800-21813
        • El Khoury R.
        • et al.
        3D bioprinted spheroidal droplets for engineering the heterocellular coupling between cardiomyocytes and cardiac fibroblasts.
        Cyborg and Bionic Systems. 2021; 2021 (2021): 1-16
        • Porter K.E.
        • Turner N.A.
        Cardiac fibroblasts: at the heart of myocardial remodeling.
        Pharmacol therap. 2009; 123: 255-278
        • Kohl P.
        • et al.
        Electrical coupling of fibroblasts and myocytes: relevance for cardiac propagation.
        Journal of electrocardiology. 2005; 38: 45-50
        • Alonzo M.
        • et al.
        3D Biofabrication of a Cardiac Tissue Construct for Sustained Longevity and Function.
        ACS Applied Materials & Interfaces. 2022; 14: 21800-21813
        • Au - Leach M.K.
        • et al.
        Electrospinning fundamentals: optimizing solution and apparatus parameters.
        JoVE. 2011; : e2494
        • Venugopal J.R.
        • et al.
        Biomaterial strategies for alleviation of myocardial infarction.
        J Royal Soc Interface. 2012; 9: 1-19
        • You Y.
        • et al.
        In vitro degradation behavior of electrospun polyglycolide, polylactide, and poly (lactide-co-glycolide).
        J Applied Polymer Sci. 2005; 95: 193-200
        • Sowmya B.
        • Hemavathi A.B.
        • Panda P.K.
        Poly (ε-caprolactone)-based electrospun nano-featured substrate for tissue engineering applications: a review.
        Progress in biomaterials. 2021; 10: 91-117
        • Lobo A.O.
        • et al.
        Electrospun nanofiber blend with improved mechanical and biological performance.
        Int j nanomed. 2018; 13: 7891-7903
        • Ma Z.
        • et al.
        Grafting of gelatin on electrospun poly (caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell orientation.
        Tissue eng. 2005; 11: 1149-1158
        • Kim P.-H.
        • Cho J.-Y.
        Myocardial tissue engineering using electrospun nanofiber composites.
        BMB rep. 2016; 49: 26-36
        • Nagiah N.
        • et al.
        Development and characterization of furfuryl-gelatin electrospun scaffolds for cardiac tissue engineering.
        ACS Omega. 2022; 7: 13894-13905
        • Nosé Dr, Y.
        • Michael E
        DeBakey and his contributions in the field of artificial organs.
        Wiley Periodicals Inc., Hoboken, New Jersey, U.S.2008: 661-666 (September 7, 1908–July 11, 2008)
        • Stewart S.F.
        • Lyman D.J.
        Effects of a vascular graft/natural artery compliance mismatch on pulsatile flow.
        J biomech. 1992; 25: 297-310
        • Weinberg C.B.
        • Bell E.
        A blood vessel model constructed from collagen and cultured vascular cells.
        Science. 1986; 231: 397-400
        • Tillman B.W.
        • et al.
        The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction.
        Biomaterials. 2009; 30: 583-588
        • Du F.
        • et al.
        Gradient nanofibrous chitosan/poly ɛ-caprolactone scaffolds as extracellular microenvironments for vascular tissue engineering.
        Biomaterials. 2012; 33: 762-770
        • Tian L.
        • et al.
        Emulsion electrospun nanofibers as substrates for cardiomyogenic differentiation of mesenchymal stem cells.
        J Materials Sci: Materials in Med. 2013; 24: 2577-2587
        • Wang T.
        • et al.
        Bone marrow stem cells implantation with α-cyclodextrin/MPEG–PCL–MPEG hydrogel improves cardiac function after myocardial infarction.
        Acta biomaterialia. 2009; 5: 2939-2944
        • Liu W.
        • Thomopoulos S.
        • Xia Y.
        Electrospun nanofibers for regenerative medicine.
        Advanced healthcare materials. 2012; 1: 10-25
        • Sahoo S.
        • et al.
        Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications.
        J Biomed Materials Res Part A: An Off J Soc Biomaterials, The Japanese Soc for Biomaterials, and The Australian Soc for Biomaterials and the Korean Soc for Biomaterials. 2010; 93: 1539-1550
        • Kharaziha M.
        • et al.
        PGS: Gelatin nanofibrous scaffolds with tunable mechanical and structural properties for engineering cardiac tissues.
        Biomaterials. 2013; 34: 6355-6366
        • Leor J.
        • et al.
        Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?.
        Circulation. 2000; 102 (Iii-56-Iii-61): lii56-lii61
        • Radisic M.
        • et al.
        Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds.
        Proc Natl Acad Sci. 2004; 101: 18129-18134
        • Gao J.
        • Crapo P.M.
        • Wang Y.
        Macroporous elastomeric scaffolds with extensive micropores for soft tissue engineering.
        Tissue eng. 2006; 12: 917-925
        • Chen Q.-Z.
        • et al.
        Characterisation of a soft elastomer poly (glycerol sebacate) designed to match the mechanical properties of myocardial tissue.
        Biomaterials. 2008; 29: 47-57
        • Osaki T.
        • Sivathanu V.
        • Kamm R.D.
        Engineered 3D vascular and neuronal networks in a microfluidic platform.
        Scientific reports. 2018; 8: 1-13
        • Wu C.
        • et al.
        Cell-laden electroconductive hydrogel simulating nerve matrix to deliver electrical cues and promote neurogenesis.
        ACS applied materials & interfaces. 2019; 11: 22152-22163
        • Ren K.
        • et al.
        Self-healing conductive hydrogels based on alginate, gelatin and polypyrrole serve as a repairable circuit and a mechanical sensor.
        J Materials Chem B. 2019; 7: 5704-5712
        • Heo D.N.
        • et al.
        Development of 3D printable conductive hydrogel with crystallized PEDOT: PSS for neural tissue engineering.
        Materials Sci Eng: C. 2019; 99: 582-590
        • Klabunde R.E.
        Cardiac electrophysiology: normal and ischemic ionic currents and the ECG.
        Adv Physiol Educ. 2017; 41: 29-37
        • Neher E.
        • Sakmann B.
        The patch clamp technique.
        Scientific American. 1992; 266: 44-51
        • Lee J.J.
        • et al.
        Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation.
        Stem Cell Res. 2017; 25: 83-87
        • Amin H.
        • et al.
        Electrical responses and spontaneous activity of human iPS-derived neuronal networks characterized for 3-month culture with 4096-electrode arrays.
        Frontiers in neurosci. 2016; 10: 121
        • Li Q.
        • et al.
        Cyborg organoids: implantation of nanoelectronics via organogenesis for tissue-wide electrophysiology.
        Nano letters. 2019; 19: 5781-5789
        • Ao Z.
        • et al.
        Human spinal organoid-on-a-chip to model nociceptive circuitry for pain therapeutics discovery.
        Analytical Chemistry. 2021;
        • Carrow J.K.
        • et al.
        Widespread changes in transcriptome profile of human mesenchymal stem cells induced by two-dimensional nanosilicates.
        Proc Natl Acad Sci. 2018; 115: E3905-E3913
        • Carrow J.K.
        • et al.
        Photothermal modulation of human stem cells using light-responsive 2D nanomaterials.
        Proc Natl Acad Sci. 2020; 117: 13329-13338
        • Artap S.
        • et al.
        Endocardial Hippo signaling regulates myocardial growth and cardiogenesis.
        Developmental biology. 2018; 440: 22-30
        • Hwang B.
        • Lee J.H.
        • Bang D.
        Single-cell RNA sequencing technologies and bioinformatics pipelines.
        Exp Mol Med. 2018; 50: 1-14
        • Paik D.T.
        • et al.
        Single-cell RNA sequencing in cardiovascular development, disease and medicine.
        Nat Rev Cardiol. 2020; 17: 457-473
        • Ma Y.
        • et al.
        Integrative differential expression and gene set enrichment analysis using summary statistics for scRNA-seq studies.
        Nat Commun. 2020; 11: 1585
        • Kerr C.M.
        • et al.
        Multicellular human cardiac organoids transcriptomically model distinct tissue-level features of adult myocardium.
        Int J Mol Sci. 2021; 22: 8482-8493
        • Mills R.J.
        • et al.
        Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest.
        Proc Natl Acad Sci U S A,. 2017; 114: E8372-E8381
        • Rossi G.
        • et al.
        Capturing cardiogenesis in gastruloids.
        Cell Stem Cell. 2021; 28 (e6): 230-240
        • Richards D.J.
        • et al.
        Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity.
        Nat Biomed Eng. 2020; 4: 446-462
        • Caicedo J.C.
        • et al.
        Data-analysis strategies for image-based cell profiling.
        Nat Methods. 2017; 14: 849-863
        • Gritti N.
        • et al.
        MOrgAna: accessible quantitative analysis of organoids with machine learning.
        Development. 2021; 148: 1-8
        • Toepfer C.N.
        • et al.
        SarcTrack.
        Circ Res. 2019; 124: 1172-1183
        • Strobel H.A.
        • et al.
        Quantifying vascular density in tissue engineered constructs using machine learning.
        Frontiers in Physiol. 2021; 12: 650714
        • Otsu N.
        A threshold selection method from gray-level histograms.
        IEEE transac on systems, man, and cybernetics. 1979; 9: 62-66
        • Vincent L.
        • Soille P.
        Watersheds in digital spaces: an efficient algorithm based on immersion simulations.
        IEEE Transac Pattern Analysis & Machine Intelligence. 1991; 13: 583-598
        • Langhans S.A.
        Three-dimensional in vitro cell culture models in drug discovery and drug repositioning.
        Front Pharmacol. 2018; 9: 6
        • Eder A.
        • et al.
        Human engineered heart tissue as a model system for drug testing.
        Adv Drug Deliv Rev. 2016; 96: 214-224
        • Turnbull I.C.
        • et al.
        Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.
        Faseb j. 2014; 28: 644-654
        • Van Winkle A.P.
        • Gates I.D.
        • Kallos M.S.
        Mass transfer limitations in embryoid bodies during human embryonic stem cell differentiation.
        Cells Tissues Organs. 2012; 196: 34-47
        • Phelan M.A.
        • Lelkes P.I.
        • Swaroop A.
        Mini and customized low-cost bioreactors for optimized high-throughput generation of tissue organoids.
        in Stem Cell Investig. 2018; : 33
        • Zhou B.
        • Pu W.T.
        More than a cover: epicardium as a novel source of cardiac progenitor cells.
        Regen Med. 2008; 3: 633-635
        • Pang J.K.S.
        • et al.
        Insights to heart development and cardiac disease models using pluripotent stem cell derived 3D organoids.
        Front Cell Dev Biol. 2021; 9788955
        • Miyamoto M.
        • et al.
        Heart organoids and tissue models for modeling development and disease.
        Semin Cell Dev Biol. 2021; 118: 119-128
        • Chen I.Y.
        • Matsa E.
        • Wu J.C.
        Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.
        Nat Rev Cardiol. 2016; 13: 333-349
        • Burnett S.D.
        • et al.
        Cardiotoxicity hazard and risk characterization of toxcast chemicals using human induced pluripotent stem cell-derived cardiomyocytes from multiple donors.
        Chem Res Toxicol. 2021; 34: 2110-2124
        • Burnett S.D.
        • et al.
        Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization.
        Expert Opin Drug Metab Toxicol. 2021; 17: 887-902
        • Lei C.L.
        • et al.
        Tailoring mathematical models to stem-cell derived cardiomyocyte lines can improve predictions of drug-induced changes to their electrophysiology.
        Frontiers in physiol. 2017; 8: 986
        • Kowalczewski A.
        • et al.
        Integrating nonlinear analysis and machine learning for human induced pluripotent stem cell-based drug cardiotoxicity testing.
        J Tissue Eng Regen Med. 2022; 16: 732-743